Kawase K, Yoshida K, Hara K, Hidaka S, Takeyama H. Efficacy and safety of neoadjuvant chemotherapy with dose de-escalation tri-weekly nanoparticle albumin-bound paclitaxel and FEC for human epidermal growth factor receptor 2-positive breast cancer. Clinical Medicine Insights [Internet]. 2023 Jun. 9 [cited 2024 Dec. 22];4(2):378-86. Available from: http://medicineinsights.info/index.php/cmi/article/view/179